Colon adenocarcinoma and Birt–Hogg–Dubé syndrome in a young patient: case report and exploration of pathologic implications
暂无分享,去创建一个
[1] W. Linehan,et al. Seventh BHD international symposium: recent scientific and clinical advancement , 2022, Oncotarget.
[2] W. Linehan,et al. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect , 2021, Nature Structural & Molecular Biology.
[3] E. Sattler,et al. Colorectal cancer risk in families with Birt-Hogg-Dubé syndrome increased. , 2021, European journal of cancer.
[4] T. Hofmann,et al. The Role of p53 Signaling in Colorectal Cancer , 2021, Cancers.
[5] J. Nemunaitis,et al. Adenomatous polyposis coli in cancer and therapeutic implications , 2021, Oncology reviews.
[6] L. Ricciardiello,et al. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer? , 2020, Cellular and molecular gastroenterology and hepatology.
[7] H. Meijers-Heijboer,et al. No evidence for increased prevalence of colorectal carcinoma in 399 Dutch patients with Birt-Hogg-Dubé syndrome , 2019, British Journal of Cancer.
[8] A. Wysong,et al. Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt-Hogg-Dube Syndrome. , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[9] R. Müller,et al. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer , 2017, BMC Medical Genetics.
[10] L. Schmidt,et al. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation , 2016, Human molecular genetics.
[11] Philip F. Hughes,et al. The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding , 2016, Nature Communications.
[12] A. Lencastre,et al. Birt-Hogg-Dubé syndrome* , 2013, Anais brasileiros de dermatologia.
[13] A. Pause,et al. Birt–Hogg–Dubé: tumour suppressor function and signalling dynamics central to folliculin , 2013, Familial Cancer.
[14] M. Arends. Pathways of Colorectal Carcinogenesis , 2013, Applied immunohistochemistry & molecular morphology : AIMM.
[15] I. Tomlinson,et al. Investigation of the Birt–Hogg–Dubé tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer , 2010, Journal of Medical Genetics.
[16] T. Kobayashi,et al. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein , 2008, Oncogene.
[17] J. Hartley,et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling , 2006, Proceedings of the National Academy of Sciences.
[18] W. Linehan,et al. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. , 2005, Journal of the National Cancer Institute.
[19] S. Richard,et al. Clinical and genetic studies of Birt-Hogg-Dubé syndrome , 2002, Journal of medical genetics.
[20] Maria Merino,et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. , 2002, Cancer cell.
[21] P. Choyke,et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] B. Zbar,et al. Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. , 1999, Archives of dermatology.
[23] M. Benson,et al. Bilateral renal cell carcinoma in the Birt-Hogg-Dubé syndrome. , 1993, Journal of the American Academy of Dermatology.
[24] W. J. Dubé,et al. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. , 1977, Archives of dermatology.
[25] Thierry Soussi,et al. APC gene: database of germline and somatic mutations in human tumors and cell lines , 1996, Nucleic Acids Res..